Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Glyscend concludes Phase I trial of oral type 2 diabetes therapy,

Glyscend Therapeutics has concluded the Phase I clinical trial for its oral, gut-restricted, polymer therapeutic, GLY-200, to treat type 2 …, Glyscend Therapeutics has concluded the Phase I clinical trial for its oral, gut-restricted, polymer therapeutic, GLY-200, to treat type 2 …, Read More

Scroll to Top